8-K current report · filed Oct 7, 2026

Boston Scientific (BSX) 8-K Current Report: October 7, 2026

Item 5.02Item 8.01Item EX-99.1BSX overview

Short answer

Boston Scientific (BSX) filed an 8-K current report with the SEC on October 7, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Joe Fitzgerald promoted to COO effective January 1, 2027, expanding oversight from Cardiovascular to companywide operations.

Boston Scientific 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Joe Fitzgerald promoted to COO effective January 1, 2027, expanding oversight from Cardiovascular to companywide operations
  • COO compensation: $1,050,000 base salary, 110% annual bonus target, and $7,000,000 2027 equity award
  • Equity award includes options and RSUs, including performance-based RSUs, vesting 25% annually
  • Mark Bickel appointed Chief Accounting Officer effective March 1, 2027, succeeding Emily Woodworth
  • Woodworth’s transition is not related to disagreements over financial statements, controls, operations, policies, or practices

Item 8.01 · Other Events

  • Exhibit 99.1 contains Boston Scientific’s October 7, 2026 press release
  • Announcement concerns the officer or director changes described under Item 5.02
  • Investor focus: leadership transition, succession implications and any disclosed compensation terms

Item EX-99.1 · Exhibit EX-99.1

  • Joseph M. Fitzgerald named executive vice president and COO effective January 1, 2027
  • COO will oversee global operations, business units and regions, creating a significant execution responsibility
  • Three reportable segments begin January 1, 2027: Interventional Therapies, Rhythm Solutions and MedSurg
  • New structure targets faster decisions and strategic investment allocation, but adds execution and integration risk
  • Interventional Therapies expected to include Penumbra after anticipated acquisition closing

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Boston Scientific 8-K filings

Get the next BSX 8-K as it lands

Follow BSX for push alerts, or ask the research agent what this filing means.